Professor Doug Hanahan and Associate Professor Kate Burbury, Peter Mac, discuss the hallmarks of cancer and impact on advanced treatments. A recent study has discovered which proteins activate genes, and in another, real time imaging showed reactions to chemotherapy differs depending on type of cancer cell mutation. The European Medicines Agency has questioned trial designs and approvals for 32 new cancer drugs; researchers emphasised the ‘risk’ of bias due to the complex nature of cancer trials. |
| | | Tuesday 17 September - Monday 23 September | | | The Medical News • Sep 21, 2019 2:57 | | | Study provides new insight into how cells maintain their identity In the body's cells, some proteins are of vital importance as to which genes are active or turned off. Now, researchers from the University... or turned off. Now, researchers from the University of Copenhagen and the Memorial Sloan Kettering Cancer Center have discovered which |
|
| | The Medical News • Sep 20, 2019 22:40 | | | Research shows how bowel cancer screening helps reduce deaths New research led by the University of South Australia shows just how effective bowel cancer screening is in helping to reduce the number of... New research led by the University of South Australia shows just how effective bowel cancer screening is in helping to reduce the number of |
|
| | https://www.nationaltribune.com.au • Sep 20, 2019 12:3 | | | More than $3 million for leading science facility The Palaszczuk Government is investing in a key science facility that is at the forefront of research into the battle against the third... science facility that is at the forefront of research into the battle against the third most common cancer diagnosed in Australia, melanoma. |
|
| | EZ Australia • Sep 20, 2019 6:39 | | | Advancing world-leading pancreatic cancer research by Dr. Belinda Lee Honorary, Medical Biology (W.E.H.I.) Pancreatic cancer is the fifth most common cause of cancer death in Australia and... The program is a collaborative effort between the Walter and Eliza Hall Institute, University of Melbourne, and 11 Victorian cancer centres. |
|
| | Science Media Exchange - Scimex • Sep 19, 2019 8:53 | | | Cancer drug approvals based on flawed trials About half of trials that supported new cancer drug approvals had flaws in their trial design, according to researchers examining trials... of trials that supported new cancer drug approvals had flaws in their trial design, according to researchers examining trials between 2014 |
|
| | The Canberra Times (Licensed by Copyright Agency) • Sep 18, 2019 16:30 | | | ONJ in QT at Parliament House Looking perennially youthful eight days before her 71st birthday and in good spirits despite reportedly battling... the Olivia Newton-John Cancer Research Institute & Minderoo, on the success of the rare cancer clinical trials being delivered at the ONJCRI |
|
| | ABC News • Sep 18, 2019 8:7 | | | How Doug Hanahan’s research changed the cancer fight Image: Professor Doug Hanahan, pictured in a lab in Melbourne. (Victorian Comprehensive Cancer Centre: Lee Byrne) In 2000, Professor Doug... Professor Doug Hanahan, pictured in a lab in Melbourne. (Victorian Comprehensive Cancer Centre: Lee Byrne) In 2000, Professor Doug Hanahan |
|
| | Science Media Exchange - Scimex • Sep 17, 2019 19:23 | | | Discovering why chemotherapy only works for some cancer patients Researchers at Children’s Medical Research Institute in Sydney have demonstrated why chemotherapy drugs work better with some types of... Discovering why chemotherapy only works for some cancer patients |
|
|
|
|
|
|
